Skip to content

What is the classification of hemophilia? A comprehensive guide

4 min read

Hemophilia affects approximately 1 in 10,000 people globally, with severity determined by the level of a specific clotting factor. The answer to what is the classification of hemophilia? is based on both the type of deficient factor and the severity of that deficiency.

Quick Summary

The classification of hemophilia is based on the specific clotting factor deficiency, primarily Hemophilia A (factor VIII) and Hemophilia B (factor IX), and is further categorized into mild, moderate, or severe based on the factor's activity level in the blood.

Key Points

  • Categorization by Factor Deficiency: Hemophilia is fundamentally classified by the missing or defective clotting factor, most commonly Factor VIII (Hemophilia A) or Factor IX (Hemophilia B).

  • Severity by Activity Level: A secondary classification places the condition into mild, moderate, or severe categories based on the percentage of normal clotting factor activity present in the blood.

  • Genetic Inheritance: Hemophilia A and B are X-linked recessive disorders, meaning they are far more prevalent and symptomatic in males.

  • Diagnostic Methods: A diagnosis is confirmed through specific blood tests, such as the Activated Partial Thromboplastin Time (APTT) and factor assays, which precisely measure clotting factor levels.

  • Manifestations of Severity: The level of severity directly influences the clinical picture, from bleeding only after major trauma in mild cases to frequent spontaneous internal bleeding in severe cases.

  • Prognosis and Treatment: Modern medical care, including prophylactic therapy, allows individuals with hemophilia to effectively manage their bleeding risk and minimize complications, regardless of their severity classification.

In This Article

Understanding the Types of Hemophilia

Hemophilia is a rare inherited bleeding disorder that prevents blood from clotting properly, which can lead to prolonged internal and external bleeding. The initial classification is based on the specific clotting factor that is missing or deficient. This deficiency is caused by a genetic mutation, typically on the X chromosome for the two most common types.

Hemophilia A: The Most Common Type

Around 80% of all hemophilia cases are Hemophilia A, often called "classic hemophilia".

  • Cause: A deficiency or mutation in the gene responsible for producing blood clotting Factor VIII.
  • Inheritance: It is an X-linked recessive disorder, primarily affecting males. Females can be carriers of the gene.

Hemophilia B: Christmas Disease

Accounting for the other major portion of cases, Hemophilia B is also known as "Christmas disease," named after the first patient diagnosed with this specific factor deficiency.

  • Cause: A deficiency or mutation in the gene for blood clotting Factor IX.
  • Inheritance: Like Hemophilia A, this type is also an X-linked recessive disorder and predominantly affects males.

Hemophilia C: A Rare Variation

Though far less common, some health care providers refer to a Factor XI deficiency as Hemophilia C. It's unique in that it affects both males and females, as the gene is located on a different chromosome than Factors VIII and IX. For most patients, the symptoms are mild.

Classifying Severity Based on Factor Levels

Beyond the type, hemophilia is further classified by its severity, which is determined by the percentage of clotting factor activity in a person's blood. This baseline factor activity level is measured before any treatment is given.

Severe Hemophilia

  • Factor Level: Less than 1% of normal factor activity.
  • Symptoms: This is the most severe form, characterized by frequent, spontaneous bleeding into joints and muscles without any obvious cause. It is often diagnosed in the first months of life.

Moderate Hemophilia

  • Factor Level: 1% to 5% of normal factor activity.
  • Symptoms: Individuals may experience bleeding episodes after injuries, minor trauma, or surgery. Spontaneous bleeding is less frequent than in severe cases.

Mild Hemophilia

  • Factor Level: 6% to 49% of normal factor activity.
  • Symptoms: Often the least noticeable form, with bleeding typically only occurring after significant trauma, major surgery, or dental work. The first bleeding episode might not occur until adulthood.

The Genetic Basis of Hemophilia A and B

The inheritance pattern of Hemophilia A and B is a key aspect of their classification. The genes for both Factor VIII and Factor IX are located on the X chromosome. Since males have one X and one Y chromosome, a single defective gene on their X chromosome is enough to cause hemophilia. Females, with two X chromosomes, must have a defective gene on both to be severely affected, which is extremely rare. However, a female with one affected X chromosome is considered a carrier and can pass the gene to her children.

Diagnosis: A Two-Part Process

Diagnosing hemophilia involves a combination of screening tests and specific factor assays.

  1. Screening Tests: The most common is the Activated Partial Thromboplastin Time (APTT) test, which measures how long it takes for a blood sample to clot. A longer-than-normal clotting time can indicate a problem with the intrinsic pathway, where Factors VIII and IX are involved.
  2. Factor Assays: These tests measure the precise amount of clotting factor activity in the blood, confirming the specific type and severity of hemophilia.

Comparison of Hemophilia Severity Levels

This table summarizes the core differences between the severity levels of hemophilia, primarily for types A and B.

Feature Mild Hemophilia Moderate Hemophilia Severe Hemophilia
Factor Activity Level 6% to 49% 1% to 5% <1%
Bleeding Frequency Rare, usually only after major injury or surgery Episodes after minor injuries; occasional spontaneous bleeds Frequent spontaneous bleeding into joints and muscles
Onset of Symptoms Often delayed until puberty or adulthood Typically recognized in childhood Often manifests in infancy
Joint Damage Risk Low, if managed appropriately Elevated risk with recurrent bleeding High risk due to frequent joint bleeds

Conclusion

Understanding what is the classification of hemophilia? is vital for diagnosis, prognosis, and effective treatment. The dual classification system, based on both the specific factor deficiency (Type A, B) and the severity of that deficiency (mild, moderate, severe), provides a comprehensive framework for healthcare professionals. With modern treatment protocols, including prophylactic factor replacement and newer therapies, individuals with all levels of hemophilia can lead full and productive lives, managing their condition with informed care. For more detailed information on managing hemophilia and its treatments, consider resources from the Centers for Disease Control and Prevention at https://www.cdc.gov/hemophilia/about/index.html.

Frequently Asked Questions

The primary difference lies in the specific clotting factor that is deficient. Hemophilia A involves a deficiency in Factor VIII, while Hemophilia B is caused by a deficiency in Factor IX.

Severity is determined by measuring the level of clotting factor activity in the blood. A level less than 1% is severe, 1-5% is moderate, and 6-49% is mild.

Yes, while Hemophilia A and B are typically X-linked and more common in males, females can be affected. Those with one defective gene are usually carriers, but can sometimes exhibit mild symptoms. Hemophilia C affects both genders equally.

Currently, there is no cure for hemophilia, but it is highly treatable. Treatment involves replacing the missing clotting factor to prevent and control bleeding episodes. Gene therapy is a new, promising area of research.

In severe cases, signs often appear in infancy and can include frequent, unexplained spontaneous bleeding into joints and muscles, which can cause pain and swelling.

Diagnosis begins with screening tests like the Activated Partial Thromboplastin Time (APTT) test. If results are abnormal, specific factor assays are performed to identify the exact factor deficiency and its severity.

Acquired hemophilia is a rare autoimmune disorder where the immune system attacks and damages a person's own clotting factors, rather than the condition being inherited. It can occur later in life.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.